Company Overview and News

 
Oakmark Global Fund: Q1 2018

7h seekingalpha
The Oakmark Global Fund felt the downtrend’s pull and lost 2.6% in the quarter, which compares to a 1.3% loss for the MSCI World Index and a 1.0% loss for the Lipper Global Fund Index.
Upvote Downvote

 
Ten years' jail for tax scam that broke records

2018-03-29 theage.com.au
Controversial Gold Coast businessman Michael Issakidis has been sentenced to 10 years in jail over his role in a $135 million tax avoidance scam said to be the largest tax avoidance case successfully prosecuted in Australian history.
Upvote Downvote

 
Ten years' jail for tax scam that broke records

2018-03-29 smh.com.au
Controversial Gold Coast businessman Michael Issakidis has been sentenced to 10 years in jail over his role in a $135 million tax avoidance scam said to be the largest tax avoidance case successfully prosecuted in Australian history.
Upvote Downvote

 
Orica claims BHP, Roy Hill explosives contracts

2018-03-02 australianmining.com.au
Orica has confirmed that it is the new explosives supplier for BHP and Roy Hill at their iron ore operations in the Pilbara region.
Upvote Downvote

 
Telstra feeling the pressure of NBN rollout

2018-01-22 perthnow.com.au
TELSTRA may need to cut costs more aggressively as revenue comes under pressure amid the rollout of the National Broadband Network and intense competition, Australia’s biggest listed investment company says.
Upvote Downvote

 
Mega Miners May Snap Australian Stocks’ Two-Day Losing Streak - Bloomberg

2018-01-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Roy Hill to end Incitec Pivot explosives contract

2018-01-12 australianmining.com.au
Incitec Pivot has lost its contract to supply explosives products and services to Pilbara iron ore miner Roy Hill.
Upvote Downvote

 
Incitec loses Roy Hill contract

2018-01-11 businessnews.com.au
Melbourne-based fertiliser and explosives manufacturer Incitec Pivot has lost its second major West Australian supply contract in two months, with iron ore miner Roy Hill to allow its purchase agreement to expire in February.
Upvote Downvote

 
BHP ends Pilbara contract with Incitec Pivot

2017-12-07 australianmining.com.au
Incitec Pivot’s contract to supply ammonium nitrate prill to BHP’s iron ore operations in the Pilbara will end in late 2019.
Upvote Downvote

 
Incitec Pivot hit by end of BHP contract

2017-12-06 businessnews.com.au
Incitec Pivot has warned that its 2020 and 2021 full-year profits will be hit by the end of a contract to supply ammonium nitrate prill to mining giant BHP Billiton.
Upvote Downvote

 
Why the ASX will beat Wall St in 2018: Macquarie

2017-12-06 theage.com.au
The ASX's "sweet spot" of reasonable underlying economic growth, persistently low rates, and relatively attractive valuation will make Australian shares a better investment in 2018 than their more fancied US counterparts.
Upvote Downvote

 
Why the ASX will beat Wall St in 2018: Macquarie

2017-12-06 smh.com.au
The ASX's "sweet spot" of reasonable underlying economic growth, persistently low rates, and relatively attractive valuation will make Australian shares a better investment in 2018 than their more fancied US counterparts.
Upvote Downvote

 
Coalition aims to help ADF veterans move from military into civilian careers

2017-11-17 smh.com.au
An Australian Defence Force veteran worked in the West Australian mining industry, put himself through a law degree, but running out money with a wife and two children, he applied for unemployment benefits.
Upvote Downvote

 
Woodside sell-down sparks ASX slide

2017-11-14 theage.com.au
A long-awaited "liquidity event" in Woodside Petroleum shares sparked selling across ASX bluechips and pushed the ASX 200 back below 6000 points.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...